ABIA and GTPI on Globo Radio in Brazil, on their demands for the last standing Sofosbuvir patent application to be rejected
The objective is that the INPI (National Institute of Industrial Property) does not grant the patent registry to an American laboratory for an essential remedy in the treatment of the disease.
Globo Radio | 20 August, 2018
Why India’s IP policy needs a South African tweak
It is unplugged from existing health and science & technology policies. South Africa recently adopted a new Intellectual Property Policy, which seeks to align IP with the country’s national development plan.
The Hindu Business Line | 20 July, 2018
இந்தியாவில் மருந்து காப்புரிமை முறைப்படிதான் வழங்கப்படுகிறதா?
An article on the accessibsa project’s work in The Hindu (Tamil edition)
The Hindu (Tamil Edition) | 30 May, 2018
Weed Out Evergreen Patents
A recently published report “Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed and why the system must be reformed“, by Dr. Feroz Ali, Dr. Sudarsan Rajagopal, Dr. Venkata S. Raman and Roshan John…
Live Law | 27 May, 2018
Five Years After The Indian Supreme Court’s Novartis Verdict
On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about patents and patients.